ritanserin has been researched along with Bilateral Headache in 3 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
Excerpt | Relevance | Reference |
---|---|---|
"Ritanserin was highly effective in reducing Pain Total Index and analgesic consumption in chronic headache, and its activity was similar to that observed during amitriptyline treatment." | 6.67 | A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline. ( Blandini, F; Cerutti, G; Facchinetti, F; Granella, F; Manzoni, GC; Nappi, G; Ruiz, L; Sandrini, G, 1990) |
"Ritanserin treatment was associated with a dose-related prolongation of subjects' QTc interval recording on the electrocardiogram." | 2.68 | Ritanserin in the treatment of alcohol dependence--a multi-center clinical trial. Ritanserin Study Group. ( Anton, RF; Bohn, MJ; Clyde, C; Galloway, GP; Jasinski, DR; Johnson, BA; Kranzler, H; Mason, BJ; Pettinati, HM; Rawson, R; Weinreib, R, 1996) |
"Ritanserin was highly effective in reducing Pain Total Index and analgesic consumption in chronic headache, and its activity was similar to that observed during amitriptyline treatment." | 2.67 | A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline. ( Blandini, F; Cerutti, G; Facchinetti, F; Granella, F; Manzoni, GC; Nappi, G; Ruiz, L; Sandrini, G, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Johnson, BA | 1 |
Jasinski, DR | 1 |
Galloway, GP | 1 |
Kranzler, H | 1 |
Weinreib, R | 1 |
Anton, RF | 1 |
Mason, BJ | 1 |
Bohn, MJ | 1 |
Pettinati, HM | 1 |
Rawson, R | 1 |
Clyde, C | 1 |
Ansink, BJ | 1 |
Hartman, JW | 1 |
Smakman, JG | 1 |
Nappi, G | 1 |
Sandrini, G | 1 |
Granella, F | 1 |
Ruiz, L | 1 |
Cerutti, G | 1 |
Facchinetti, F | 1 |
Blandini, F | 1 |
Manzoni, GC | 1 |
3 trials available for ritanserin and Bilateral Headache
Article | Year |
---|---|
Ritanserin in the treatment of alcohol dependence--a multi-center clinical trial. Ritanserin Study Group.
Topics: Adult; Alcoholism; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Rhinitis; Ritan | 1996 |
Ritanserin is not effective in tension headache.
Topics: Double-Blind Method; Headache; Humans; Ritanserin | 1992 |
A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline.
Topics: Adult; Amitriptyline; Chronic Disease; Depression; Double-Blind Method; Female; Headache; Humans; Ma | 1990 |